In the mouse xenograft model, SOX10 knockdown also blocked FOXD3/ERBB3 induction by Vemurafenib, reduced tumor growth and further enhanced the tumor-inhibiting capacity of Vemurafenib (Fig. 7c, d). This evidence concerns the gene FOXD3 and neoplasm.